• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: James Crowne

Good News for Mylan after Hellish Week: Another Win in Patent War Over MS Drug; Lawyers on Both Sides Rejoice.

Steve Walker    September 8, 2016 September 6, 2017    No Comments on Good News for Mylan after Hellish Week: Another Win in Patent War Over MS Drug; Lawyers on Both Sides Rejoice.

Teva Pharmaceutical Industries Ltd. (Petach Tikva ISR) had a third patent on its top-selling multiple sclerosis drug, Copaxone, invalidated last Thursday by a U.S. agency, a further blow to its… Read more »

Corporate, Disease, Government    American Intellectual Property Law Association, Amneal Pharmaceuticals LLC, Aude Gerspacher, Bloomberg Intelligence, Copaxone, Credit Suisse, Epipen, FiercePharma.com, Full Employment for Lawyers Act, Health Affairs, Heather Bresch, Inter Partes Review, James Crowne, Jason Gerberry, Leerink Partners, Momenta Pharmaceuticals Inc., Multiple Sclerosis, Mylan NV, Novartis AG, Patent and Trademark Office, Patent Trial and Appeal Board, Pharmaceutical Manufacturers Association, Randall Stanicky, RBC Capital Markets, Teva Pharmaceuticals, U.S. Food and Drug Administration, Vamil Divan

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Reducing salt consumption may protect against Alzheimer’s. Considering the stakes, start now.
  • US stock market has a subdued Thanksgiving week, but a slew of healthcare companies rocketed higher.
  • More Chinese medical companies choosing New York over Shanghai, Hong Kong for IPOs; but not always.
  • Health-sector IPO market cools off for Veterans Day breather; but pre-Thanksgiving deals ready to rock.
    • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
    • Voyager Therapeutics signs another neurodegenerative disease deal with AbbVie that screams “Buy this small cap now.”
    • Little known Czech biotech’s cell therapy greatly increases survival in ovarian cancer. Sotio’s potential breakthrough and another pipeline cancer candidate...
    • Powered only by heart muscle, experimental pacemaker doesn’t need new batteries. Goodbye (hopefully) to battery-replacement surgery; but hello international patent...
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress